XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.4
STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (5,531,360) $ 1,245,902
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 502,540 154,821
Share-based payments for services 155,740 238,904
Equity based compensation 1,800,225 573,660
Common stock contributed to 401(k) plan 40,937 35,241
Gain on derivative instruments (766,509) (5,556,306)
Capitalized lease interest 0 34,223
(Increase)/decrease in assets:    
Receivables (28,278) (10,105)
Prepaid expenses 86,567 (105,685)
Supplies used for R&D and manufacturing (123,512) (37,287)
Increase/(decrease) in liabilities:    
Accounts payable (393,064) (734,770)
Accrued expenses 80,432 (127,600)
Due to employees 76,520 131,892
Other liabilities (1,914) (369)
Net cash used in operating activities (4,101,676) (4,157,479)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (101,820) (6,132)
Proceeds from sale of equipment 4,500 0
Expenditures for patent costs (12,390) (66,131)
Net cash used in investing activities (109,710) (72,263)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 5,050,003 0
Payments of stock issuance costs (31,080) (46,599)
Proceeds from the purchase of stock by officers and directors 25,000 0
Proceeds from exercise of warrants 297,101 649,753
Payments on obligations under finance lease (191,034) (1,251)
Net cash provided by financing activities 5,149,990 601,903
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 938,604 (3,627,839)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 8,444,774 10,310,044
CASH AND CASH EQUIVALENTS, END OF PERIOD 9,383,378 6,682,205
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Property and equipment included in current liabilities 296,941 0
Finance lease obligation included in accounts payable 745 421
Prepaid consulting services paid with issuance of common stock (71,293) (36,524)
Financing costs included in current liabilities 76,650 0
Cash paid for interest expense $ 295,107 $ 448,486